BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$3.89 -0.05 (-1.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Amortization of Deferred Charges (2025 - 2026)

Updated

BridgeBio Oncology Therapeutics (BBOT) reported Amortization of Deferred Charges of $115,000 for Q2 2026, up 2.7% from $112,000 a year earlier and up 2.7% from the prior quarter.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, BridgeBio Oncology Therapeutics' Amortization of Deferred Charges came in at $339,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 BridgeBio Oncology Therapeutics 311.65 Mn -1.06 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 115,000.00
Mar 31, 2026 112,000.00
Jun 30, 2025 112,000.00
API Access

BridgeBio Oncology Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=BBOT&period=max&api_key=YOUR_API_KEY